SCHEMBL13357558

SCHEMBL13357558

Clc1ccccc1C/N=C(/NCc1ccccc1)NCc1ccccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ TAAR1 Q96RJ0 1/20 0.45
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ GRIN1 Q05586 2/20 0.44
▸ GRIN2B Q13224 2/20 0.44
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR3A P46098 1/20 0.44
▸ HTR3D Q70Z44 1/20 0.44
▸ HTR3C Q8WXA8 1/20 0.44
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16443508 0.78 GRIN2B (0.67) LMNAMEN1KMT2APOLBALDH1A1
SCHEMBL27942162 0.78 NPC1 (0.83) LMNANPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL25375732 0.78 NPC1 (0.66) LMNANPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL28992287 0.71 ERCC1 (0.68) LMNANPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL25376216 0.71 ALDH1A1 (0.66) LMNASMN1; SMN2MEN1KMT2APOLB
SCHEMBL16584664 0.71 ALDH1A1 (0.56) LMNANPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL5269588 0.71 GRIN2D (0.53) L3MBTL1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL973274 0.70 NPC1 (0.54) LMNANPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL11583324 0.70 CYP1A2 (0.64) LMNAMEN1KMT2APOLBGRIN1
SCHEMBL11583321 0.70 CYP1A2 (0.64) LMNAMEN1KMT2APOLBGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651613-B1 4,5-DIHYDRO-IMIDAZOLE AS P2X7 ION CHANNEL BLOCKERS AVENTIS PHARMA INC (US) 2010-05-26 — — EP disclosed
Send feedback